PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.27, sa.1, ss.99-100, 2017 (SCI-Expanded)
Objective: Comorbidity with attention deficit hyperactivity disorder (ADHD) and disruptive mood dysregulation disorders (DMDD) is very common in children and adolescents In this study, we aimed to present a retrospective study of methylphenidate (MPH) treatment in 12 cases who were diagnosed with DMDD and ADHD.